These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 6141930)

  • 1. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Dawson GW; Jue SG; Brogden RN
    Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alprazolam (Xanax, the Upjohn Company).
    Evans RL
    Drug Intell Clin Pharm; 1981 Sep; 15(9):633-8. PubMed ID: 6115742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled clinical trial of alprazolam for the treatment of anxiety.
    Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
    Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alprazolam--a new triazolobenzodiazepine.
    Talmud J; Straughan JL; Robins AH
    S Afr Med J; 1984 Aug; 66(8):297-8. PubMed ID: 6147900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study.
    Rickels K; London J; Fox I; Hassman H; Csanalosi I; Weise C
    Pharmacopsychiatry; 1991 Jul; 24(4):127-31. PubMed ID: 1754608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of alprazolam, imipramine, and placebo in the treatment of depression.
    Feighner JP; Aden GC; Fabre LF; Rickels K; Smith WT
    JAMA; 1983 Jun; 249(22):3057-64. PubMed ID: 6133970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alprazolam: pharmacokinetics, clinical efficacy, and mechanism of action.
    Fawcett JA; Kravitz HM
    Pharmacotherapy; 1982; 2(5):243-54. PubMed ID: 6133268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alprazolam and diazepam in the treatment of generalized anxiety.
    Elie R; Lamontagne Y
    J Clin Psychopharmacol; 1984 Jun; 4(3):125-9. PubMed ID: 6145726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
    Davison K; Farquharson RG; Khan MC; Majid A
    Psychopharmacology (Berl); 1983; 80(4):308-10. PubMed ID: 6137856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J; Schless AP
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
    Feighner JP; Meredith CH; Frost NR; Chammas S; Hendrickson G
    Acta Psychiatr Scand; 1983 Oct; 68(4):223-33. PubMed ID: 6138925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM
    J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness.
    Lenox RH; Shipley JE; Peyser JM; Williams JM; Weaver LA
    Psychopharmacol Bull; 1984; 20(1):79-82. PubMed ID: 6144136
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
    Casacalenda N; Boulenger JP
    Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
    Davison K; Farquharson RG; Khan MC; Majid A
    Br J Clin Pharmacol; 1985; 19 Suppl 1(Suppl 1):37S-43S. PubMed ID: 2859877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
    Chouinard G; Labonte A; Fontaine R; Annable L
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):669-73. PubMed ID: 6141609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepines as antidepressants: does GABA play a role in depression?
    Petty F; Trivedi MH; Fulton M; Rush AJ
    Biol Psychiatry; 1995 Nov; 38(9):578-91. PubMed ID: 8573660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.